AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects

Journal of Applied Physiology

Volumn 103, Issue 1, 2007, Pages 315-322

  Fischer, Heléne ^a   Esbjörnsson, Mona ^a   Sabina, Richard L ^c   Strömberg, Anna ^a   Peyrard Janvid, Myriam ^b   Norman, Barbara ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Exercise; Fatigue; Lactate; Myoadenylate deaminase deficiency; Skeletal muscle

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE;

ADENOSINE PHOSPHATE DEAMINASE DEFICIENCY; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CYCLING; ENZYME DEFICIENCY; EXERCISE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MALE; MUSCLE FATIGUE; MUSCLE FORCE; MUSCLE FUNCTION; NORMAL HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SEX RATIO; SKELETAL MUSCLE; STATISTICAL ANALYSIS; TASK PERFORMANCE;

ADULT; AMMONIA; AMP DEAMINASE; DNA MUTATIONAL ANALYSIS; EXERCISE; EXERCISE TEST; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LACTIC ACID; MALE; MUSCLE FATIGUE; MUSCLE FIBERS; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUTATION; PHENOTYPE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 34447643442     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00185.2007     Document Type: Article

References (36)

1. Bar-Or O, Dotan R, Inbar O, Rothstein A, Karlsson J, Tesch P. Anaerobic capacity and muscle fiber type distribution in man. Int J Sports Med 1: 82-85, 1980.
2. Bogdanis GC, Nevill ME, Boobis LH, Lakomy HK, Nevill AM. Recovery of power output and muscle metabolites following 30 s of maximal sprint cycling in man. J Physiol 482: 467-480, 1995.
3. Bouchard CTAW, Simoneau JA, Dulac S. Testing anaerobic power and capacity. In: Physiological Testing of the High-Performance Athlete, edited by MacDougall JD. Champaign, IL: Human Kinetics, 1991, p. 175-221.
4. Cooke R, Pate E. The effects of ADP and phosphate on the contraction of muscle fibers. Biophys J 48: 789-798, 1985.
5. De Ruiter CJ, May AM, van Engelen BG, Wevers RA, Steenbergen-Spanjers GC, de Haan A. Muscle function during repetitive moderateintensity muscle contractions in myoadenylate deaminase-deficient Dutch subjects. Clin Sci (Lond) 102: 531-539, 2002.
6. De Ruiter CJ, Van EBG, Wevers RA, De Haan A. Muscle function during fatigue in myoadenylate deaminase-deficient Dutch subjects. Clin Sci (Colch) 98: 579-585, 2000.
7. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32: 77-97, 1974.
8. Essen B, Jansson E, Henriksson J, Taylor AW, Saltin B. Metabolic characteristics of fibre types in human skeletal muscle. Acta Physiol Scand 95: 153-165, 1975.
9. Fishbein WN, Armbrustmacher VW, Griffin JL. Myoadenylate deaminase deficiency: a new disease of muscle. Science 200: 545-548, 1978.
10. Gross M. Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency. J Inherit Metab Dis 20: 186-192, 1997.
11. Gross M, Rotzer E, Kolle P, Mortier W, Reichmann H, Goebel HH, Lochmuller H, Pongratz D, Mahnke-Zizelman DK, Sabina RL. A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population. Neuromuscul Disord 12: 558-565, 2002.
12. Hancock CR, Janssen E, Terjung RL. Skeletal muscle contractile performance and ADP accumulation in adenylate kinase-deficient mice. Am J Physiol Cell Physiol 288: C1287-C1297, 2005.
13. Hargreaves M, McKenna MJ, Jenkins DG, Warmington SA, Li JL, Snow RJ, Febbraio MA. Muscle metabolites and performance during high-intensity, intermittent exercise. J Appl Physiol 84: 1687-1691, 1998.
14. Hebestreit H, Mimura K, Bar-Or O. Recovery of muscle power after high-intensity short-term exercise: comparing boys and men. J Appl Physiol 74: 2875-2880, 1993.
15. Inbar O, Bar-Or O, Skinner JS. The Wingate Anaerobic Test, edited by Washburn RA. Champaign, IL: Human Kinetics, 1996, p. 8-24.
16. Isackson PJ, Bujnicki H, Harding CO, Vladutiu GD. Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene. Mol Genet Metab 86: 250-256, 2005.
17. Jurinke C, van den Boom D, Cantor CR, Koster H. Automated genotyping using the DNA MassArray technology. Methods Mol Biol 187: 179-192, 2002.
18. Kavanagh MF, Jacobs I. Breath-by-breath oxygen consumption during performance of the Wingate Test. Can J Sport Sci 13: 91-93, 1988.
19. Lowenstein JM. Ammonia production in muscle and other tissues: the purine nucleotide cycle. Physiol Rev 52: 382-414, 1972.
20. Lowry OH, Passonneau JV. A Flexible System of Enzymatic Analysis. New York: Academic, 1972.
21. Morisaki T, Gross M, Morisaki H, Pongratz D, Zollner N, Holmes EW. Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci USA 89: 6457-6461, 1992.
22. Norman B, Glenmark B, Jansson E. Muscle AMP deaminase deficiency in 2% of a healthy population. Muscle Nerve 18: 239-241, 1995.
23. Norman B, Hellsten-Westing Y, Sjodin B, Jansson E. AMP deaminase in skeletal muscle of healthy males quantitatively determined by new assay. Acta Physiol Scand 150: 397-403, 1994.
24. Norman B, Mahnke-Zizelman DK, Vallis A, Sabina RL. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle. J Appl Physiol 85: 1273-1278, 1998.
25. Norman B, Sabina RL, Jansson E. Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects. J Appl Physiol 91: 258-264, 2001.
26. Rico-Sanz J, Rankinen T, Joanisse DR, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study. Physiol Genomics 14: 161-166, 2003.
27. Sabina RL, Fishbein WN, Pezeshkpour G, Clarke PR, Holmes EW. Molecular analysis of the myoadenylate deaminase deficiencies. Neurology 42: 170-179, 1992.
28. Sabina RL, Swain JL, Olanow CW, Bradley WG, Fishbein WN, DiMauro S, Holmes EW. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. J Clin Invest 73: 720-730, 1984.
29. Sinkeler SP, Binkhorst RA, Joosten EM, Wevers RA, Coerwinkei MM, Oei TL. AMP deaminase deficiency: study of the human skeletal muscle purine metabolism during ischaemic isometric exercise. Clin Sci (Colch) 72: 475-482, 1987.
30. Smith JC, Hill DW. Contribution of energy systems during a Wingate power test. Br J Sports Med 25: 196-199, 1991.
31. Stathis CG, Febbraio MA, Carey MF, Snow RJ. Influence of sprint training on human skeletal muscle purine nucleotide metabolism. J Appl Physiol 76: 1802-1809, 1994.
32. Svensson G, Anfalt T. Rapid determination of ammonia in whole blood and plasma using flow injection analysis. Clin Chim Acta 119: 7-14, 1982.
33. Tarnopolsky MA, Parise G, Gibala MJ, Graham TE, Rush JW. Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans. J Physiol 533: 881-889, 2001.
34. Verzijl HT, van Engelen BG, Luyten JA, Steenbergen GC, van den Heuvel LP, ter Laak HJ, Padberg GW, Wevers RA. Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol 44: 140-143, 1998.
35. Westerblad H, Dahlstedt AJ, Lannergren J. Mechanisms underlying reduced maximum shortening velocity during fatigue of intact, single fibres of mouse muscle. J Physiol 510: 269-277, 1998.
36. Westerblad H, Lannergren J. Changes of the force-velocity relation, isometric tension and relaxation rate during fatigue in intact, single fibres of Xenopus skeletal muscle. J Muscle Res Cell Motil 15: 287-298, 1994.